Thermo Fisher Scientific Inc.

TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.

zacks.com - 2026-07-15 09:51:08

On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli

gurufocus.com - 2026-07-13 07:30:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world h.

businesswire.com - 2026-07-09 17:00:00

Thermo Fisher Scientific Inc. is down 12.2% YTD, underperforming both the S&P 500 and the healthcare sector. Key risks include NIH funding uncertainty, China weakness, slow organic recovery, and integration risk from the $8.9B Clario acquisition. TMO trades at an 18% discount to its 5-year average P/E, reflecting much of the downside already priced in.

seekingalpha.com - 2026-07-09 11:29:26

SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™ System the first eligible to generate DNA profiles that can be searched against the n.

businesswire.com - 2026-07-07 08:30:00

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) is collaborating with Thermo Fisher Scientific Inc. (NYSE:TMO) to support the Phase 3 development and potential commercialization of ARCT-032, the company's investigational messenger RNA therapy for cystic fibrosis.

benzinga.com - 2026-07-02 11:32:58

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before the market opens on Thursday, July 23, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our website, www.thermofish.

businesswire.com - 2026-07-01 08:00:00

genedrive PLC (AIM:GDR, FRA:D6M) has signed a collaboration agreement with Thermo Fisher Scientific, sending its shares up 8% to 1.4p. The point-of-care pharmacogenetic testing company will develop a high-throughput laboratory test under the deal.

proactiveinvestors.co.uk - 2026-06-29 04:07:10

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase new capabilities, strategic investments and initiatives at BIO International 2026 that are helping pharma and biotech customers advance innovation, simplify complex workflows and bring therapies to patients faster. Spanning AI-enabled research, clinical development and advanced manufacturing, these investments reinforce Thermo Fisher's role as a trusted strategic provider of integrated.

businesswire.com - 2026-06-22 08:30:00

West Pharmaceutical said on Monday it appointed former Thermo Fisher Scientific executive Michel ​Lagarde as its top boss, effective ‌August 31, succeeding longtime chief Eric Green.

reuters.com - 2026-06-01 17:21:55

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled software and integrated workflows at the American Society for Mass Spectrometry (ASMS) Conference. Across research, biopharma and applied testing, scientists face increasingly complex samples, expanding data sets and greater pressure to deliver confident answers faster. Thermo Fisher helps solve that.

businesswire.com - 2026-06-01 08:30:00

Thermo Fisher (TMO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

zacks.com - 2026-05-29 10:25:16

On May 28, 2026, Thermo Fisher Scientific Inc (TMO) shares rose 6.8% today, now trading at $487.22. The stock's performance remains volatile with a 52-week rang

gurufocus.com - 2026-05-28 17:13:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ Orbitrap™ Excedion™ mass spectrometers will be showcased at the American Society for Mass Spectrometry (ASMS) Conference. As scientific discovery expands into more complex applications—from advanced proteomics and multiomics to biologics and genetic medicines—researchers and drug developers face inc.

businesswire.com - 2026-05-28 08:00:00

On May 26, 2026, we present a DCF analysis for Thermo Fisher Scientific Inc (TMO). The stock has experienced a mixed performance recently, with a year-to-date d

gurufocus.com - 2026-05-26 07:49:00

Thermo Fisher Scientific Inc. (TMO) Analyst/Investor Day Transcript

seekingalpha.com - 2026-05-22 17:40:43

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on July 15, 2026, to shareholders of record as of June 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $45 billion. Our Mission is to enable our customers to make the world healthier.

businesswire.com - 2026-05-20 17:00:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and members of the senior leadership team highlighted the company's industry leadership and the essential role of its best-in-class products and services to customers around the world. "Our customers value Thermo Fisher as their trusted partner,” said Marc N. Casper, chairman and chief executive office.

businesswire.com - 2026-05-20 08:30:00

Jefferies, an investment banking and capital management firm, has updated its ‘Franchise Picks' list, which features the company's highest-conviction ‘Buy' rated stocks.

finbold.com - 2026-05-18 10:34:06

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, located within GoCo Health Innovation City. This new facility expands the company's global bioanalytical capabilities to support pharmaceutical and biotechnology customers across all phases of drug development. With state-of-the-art instrumentation and Good Laboratory Practice (GLP) capabilities, the la.

businesswire.com - 2026-05-18 08:30:00

ROCHESTER, N.Y.--(BUSINESS WIRE)--Nalgene Outdoor today introduces the Fresh Flow™ straw bottle, a new addition to its reusable bottle collection designed to give fans more ways to hydrate without sacrificing the simplicity, durability, and approachable price points they expect from a Nalgene bottle. The result is a slim 24-oz bottle paired with a new interchangeable Fresh Flow cap that lets fans sip from a straw, chug from a spout, or swap the cap onto other Nalgene bottles they already own. T.

businesswire.com - 2026-05-11 08:30:00

On May 11, 2026, we present a discounted cash flow (DCF) analysis for Thermo Fisher Scientific Inc (TMO). The company has experienced a challenging price perfor

gurufocus.com - 2026-05-11 08:19:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, earned a Leader designation among contract research organizations (CROs) in the 2026 ISG Provider Lens™ Life Sciences Digital Services report, underscoring the company's continued investment in digital innovation across the clinical development continuum. The recognition highlights the strength of Thermo Fisher's PPD™ clinical research business, which is recognized for its capabilities in clinic.

businesswire.com - 2026-05-06 08:30:00

Examine Thermo Fisher's (TMO) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

zacks.com - 2026-05-04 10:16:14

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy developers scale manufacturing with precise control, flexibility, and regulatory readiness. As cell therapies move from early research into clinical development and commercialization, manufacturers face increasing pressure to transition from static culture systems to s.

businesswire.com - 2026-05-04 08:30:00

On May 04, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company that has experienced a price decline of 18.9% year-to-date

gurufocus.com - 2026-05-04 07:32:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the opening of its flagship U.S. Bioprocess Design Center (BDC) at the company's Plainville, Mass., site, expanding the facility to support customers in developing and scaling biologics. The new center brings together advanced bioproduction capabilities and hands-on collaboration to help customers accelerate process development and bring transformative therapies to patients faste.

businesswire.com - 2026-04-28 08:30:00

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will hold its 2026 Investor Day on Wednesday, May 20, 2026, starting at 9:00 a.m. ET in New York City. The format will feature presentations by members of Thermo Fisher Scientific's senior management team and conclude with a Q&A session. The live webcast of the presentation can be accessed via the Investors section of our website, https://ir.thermofisher.com. A replay of the webc.

businesswire.com - 2026-04-28 08:00:00

Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion.

wsj.com - 2026-04-27 09:09:00

Thermo Fisher ​Scientific said ‌on Monday it ​has ​agreed to sell ⁠its ​microbiology ​business to a pan-European ​private ​equity firm Astorg ‌for ⁠about $1.08 billion, consisting of ​cash ​and ⁠a $50 million ​seller ​note.

reuters.com - 2026-04-27 08:11:17

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food.

businesswire.com - 2026-04-27 08:00:00

On April 27, 2026, we delve into the DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently facing a challenging price performance with a year

gurufocus.com - 2026-04-27 07:28:00

Comerica Bank lessened its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 4.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,308 shares of the medical research company's stock after selling 3,787 shares during the period.

defenseworld.net - 2026-04-27 06:42:51

Concurrent Investment Advisors LLC increased its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 131.4% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,603 shares of the medical research company's stock after buying an additional

defenseworld.net - 2026-04-27 06:09:01

AEGON ASSET MANAGEMENT UK Plc reduced its stake in Thermo Fisher Scientific Inc. (NYSE: TMO) by 2.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 58,972 shares of the medical research company's stock after selling 1,644 shares during

defenseworld.net - 2026-04-26 03:10:58

The real brain computer interface opportunity isn't in the headlines. These 10 stocks are building the systems that make it possible.

investorplace.com - 2026-04-25 00:00:00

Thermo Fisher Scientific experienced a sharp post-Q1 selloff despite beating sales and EPS expectations and raising full-year guidance. Inorganic growth from recent acquisitions, notably Clario, contributed materially to raised EPS guidance and overall revenue outlook. Short-term headwinds in government/academic spending and diagnostics are not expected to derail Thermo's long-term growth strategy, supported by reshoring and AI adoption.

seekingalpha.com - 2026-04-23 21:36:32

Thermo Fisher Scientific Inc.  (NYSE:TMO) on Thursday reported first-quarter 2026 adjusted earnings of $5.44 per share, beating the street view of $5.24.

benzinga.com - 2026-04-23 15:13:16

Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-23 11:31:37

Shares of Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) were down more than 7.5% on Thursday after investors weighed a stronger-than-expected quarterly profit against muted underlying growth and a still-cautious outlook despite an upgraded full-year revenue forecast. The life sciences tools and services company reported adjusted earnings per share of $5.44 for the first quarter of fiscal 2026, beating analyst expectations of $5.25.

proactiveinvestors.com - 2026-04-23 11:02:31

TMO beats Q1 EPS and revenue estimates with steady growth, yet shares slip 4% in pre-market after results and mixed segment performance.

zacks.com - 2026-04-23 10:44:59

Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com - 2026-04-23 10:32:12

Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.44 per share, beating the Zacks Consensus Estimate of $5.2 per share. This compares to earnings of $5.15 per share a year ago.

zacks.com - 2026-04-23 08:21:05

Shares of Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) were down more than 7.5% on Thursday after investors weighed a stronger-than-expected quarterly...

proactiveinvestors.com - 2026-04-23 07:00:00

Thermo Fisher Scientific on Thursday reported first-quarter profit and revenue above Wall Street estimates, as growth ​in its laboratory products and biopharma services business ‌helped offset softness in analytical instruments and specialty diagnostics.

reuters.com - 2026-04-23 06:41:22

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026. First Quarter Highlights First quarter revenue grew 6% to $11.01 billion. First quarter GAAP diluted earnings per share (EPS) grew 11% to $4.43. First quarter adjusted EPS grew 6% to $5.44. Delivered excellent performance in the first quarter, demonstrating the strength of our proven growth strategy, the.

businesswire.com - 2026-04-23 06:00:00

Caprock Group LLC lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 21.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,304 shares of the medical research company's stock after acquiring an additional

defenseworld.net - 2026-04-23 05:16:02

Boston Trust Walden Corp lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 9.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,973 shares of the medical research company's stock after purchasing an additional

defenseworld.net - 2026-04-23 04:07:35

AE Wealth Management LLC decreased its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 92.4% during the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 5,257 shares of the medical research company's stock after selling 63,724 shares during the period. AE Wealth Management LLC's holdings

defenseworld.net - 2026-04-21 03:09:02

Thermo Fisher Scientific (TMO) remains a high-quality, stable business, but its stock is currently overvalued relative to its growth outlook. TMO reported FY25 revenue growth of 3.9% and EPS growth of 7.3%, with management guiding for 6–8% adjusted EPS growth in FY26. Despite solid fundamentals and resilient end-markets, valuation multiples near 30x earnings/free cash flow appear stretched unless double-digit growth resumes.

seekingalpha.com - 2026-04-20 11:01:45